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Abstract—The local hemodynamic shear stress waveforms
present in an artery dictate the endothelial cell phenotype.
The observed decrease of the apical glycocalyx layer on the
endothelium in atheroprone regions of the circulation sug-
gests that the glycocalyx may have a central role in
determining atherosclerotic plaque formation. However, the
kinetics for the cells’ ability to adapt its glycocalyx to the
environment have not been quantitatively resolved. Here we
report that the heparan sulfate component of the glycocalyx
of HUVECs increases by 1.4-fold following the onset of high
shear stress, compared to static cultured cells, with a time
constant of 19 h. Cell morphology experiments show that
12 h are required for the cells to elongate, but only after 36 h
have the cells reached maximal alignment to the ﬂow vector.
Our ﬁndings demonstrate that following enzymatic degrada-
tion, heparan sulfate is restored to the cell surface within 12 h
under ﬂow whereas the time required is 20 h under static
conditions. We also propose a model describing the contri-
bution of endocytosis and exocytosis to apical heparan
sulfate expression. The change in HS regrowth kinetics from
static to high-shear EC phenotype implies a differential in the
rate of endocytic and exocytic membrane turnover.
Keywords—Endothelial glycocalyx, Shear stress, Heparan
sulfate, Heparinase, Glycocalyx injury, Transport model.
INTRODUCTION
Theendothelialglycocalyxlayerontheapicalsurface
ofvascularendothelialcellsisacomplexarrangementof
proteoglycans, glycosaminoglycans (GAG), and glyco-
lipids that regulate the ability of the endothelium to
senseandrespondtoextracellularphysicalandchemical
cues. The glycocalyx has been implicated in the regula-
tion of athero-resistant gene expression,
10,29 alignment
of cells to an imposed ﬂow vector,
44 modulation of
inﬂammatory pathways,
24 and modulation of the dif-
fusionofmicro-andmacromoleculesbetweenthevessel
lumen and the cell surface.
17 Structural changes in the
glycocalyx are thought to be the initial proatherogenic
step that leads to increased afﬁnity of lipoproteins for
vascular subendothelium (reviewed in Ballinger et al.
6).
Moreover, atherosclerotic lesions exhibit heparan sul-
fate chains with signiﬁcant oxidative damage, thereby
decreasing their ability to bind growth factors.
20
Heparan sulfate (HS) is the dominant constituent of
the glycocalyx. It is a linear sulfated polysaccharide,
formed of 40–300 sugar residues, approximately 20–
150 nm in length, and is anchored to the apical core
proteins, syndecans and glypicans. HS plays an active
and necessary role in the cellular response to envi-
ronmental stimuli.
2,11 It has been implicated in the
shear-stress-induced expression of von Willebrand
factor and VE-cadherin,
26 along with the vasoregula-
tory proteins cyclooxygenase-2 (COX-2) and nitric
oxide synthase (eNOS).
26,28 Heparan sulfate also
serves as a reservoir for extracellular proteins, such as
FGF2, vascular endothelial growth factor, and lipo-
protein lipase (reviewed by Sarrazin et al.
36), and can
modulate the activity of the protein through receptor-
ligand interactions.
35
In vivo, HS is cleaved by heparanase, an endogly-
cosidase capable of selectively cleaving heparan sulfate
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160from the glycocalyx layer while leaving the core protein
intact.
9 Heparanase is found in high concentrations in
platelets, macrophages,
41 and invading tumor cells
42
and it has been suggested that normal and malignant
blood-borne cells may utilize this enzymatic machinery
to escape the vasculature.
41 High levels of glucose and
reactive oxygen species, characteristic of diabetes and
inﬂammation, respectively, increase endogenous hep-
aranase production, leading to increased arterial hep-
aran sulfate degradation.
32 Under shear stress, the
enzymatic removal of heparan sulfate from endothelial
cells results in their loss of alignment along the ﬂow
vector
44 and attenuates the production of the vasodi-
lator nitric oxide.
15 Along with matrix metallopro-
teinase activity, enzymatic degradation of the
glycocalyx also provides benign and malignant circu-
lating cells with access to the subendothelial basement
membrane.
25
The glycocalyx provides a force-sensitive region
between the ﬂowing blood vessels and the arterial wall
whose thickness depends upon the local shear forces
imposed by the ﬂuid ﬂowing at its outer surface.
33 High
shear stress increases the rate of glycocalyx biosynthesis
on porcine aortic endothelium compared to cells expe-
riencing no shear.
3 The increase in glycocalyx under
high shear stress has been noted elsewhere,
7,18,39 but its
growth kinetics under shear stress and following hepa-
ranase treatment have not been explored until now.
Here we report the time course for the regrowth of
heparan sulfate following heparinase treatment, and
explore the potential inﬂuence of endocytosis and exo-
cytosis on the rates of recovery. These ﬁndings have
application to atherosclerosis,
32 diabetes,
14 and cancer
disease models,
5,14,37 as it is becoming increasingly clear
that heparanase expression has wide-reaching and del-
eterious effects in multiple regions of the vasculature.
MATERIALS AND METHODS
Cell Culture and Reagents
Primary human umbilical vein endothelial cells
(HUVEC) were cultured in Medium 199 buﬀered with
25 mM HEPES and supplemented with 2 mM L-glu-
tamine, 20% fetal bovine serum (FBS, Gibco), and 1%
penicillin–streptomycin (Gibco). On the day of use,
50 lg/mL endothelial growth factor (ECGS, Invitro-
gen) and 100 lg/mL heparin were added. Cells were
used passage 1–3 and were kept in a humidiﬁed incu-
bator at 37  C supplied with 5% CO2. All reagents were
purchased from Sigma unless otherwise speciﬁed.
Heparinase III (cat. #50-012) was obtained from Ibex
(Montreal, Quebec, Canada) and anti-heparan sulfate
antibody 10E4 was obtained from US Biological
(Swampscott, MA). DyLight 549 IgM secondary anti-
body was purchased from Jackson Immunoresearch
(West Grove, PA). The cell preservation and imaging
medium, ProLong Gold, and the nuclear dye, 4¢,6-
diamidino-2-phenylindole dihydrochloride (DAPI),
were obtained from Invitrogen (Carlsbad, CA).
Heparan Sulfate Removal and Immunostaining
For heparan sulfate removal, the monolayer was
exposed to heparinase III (HpaseIII, 15 mU/mL) for
10 min at 37  C, then rinsed thoroughly with PBS,
covered with cell culture medium, and placed in the
incubator for a predetermined time interval. At the end
of the incubation, cells were ﬁxed with 4% parafor-
maldehyde for 15 min then blocked with 5% donkey
serum for 30 min. Cells were then treated with anti-
heparan sulfate antibody (1:100 dilution) for 30 min at
20  C, rinsed thoroughly, and treated with a ﬂuores-
cently labeled secondary antibody (1:500 dilution,
DyLight 549) for 30 min at 20  C. Cells were then
incubated with DAPI (2 lM for 5 min) and rinsed
thoroughly. Cells were quickly dried by aspiration and
covered with ProLong gold antifade mounting med-
ium. The mounting agent was allowed to cure for 24 h
protected from light before imaging.
Shear Stress Apparatus
HUVEC were seeded at 2.5 9 10
5 cells/cm
2 in Ibidi
l-slide VI ﬂow channels (Ibidi USA, Verona, WI)
coated with 0.1% gelatin and allowed to incubate at
37  C with 5% CO2 for 24 h to facilitate attachment
and growth to conﬂuent monolayers. Each Ibidi l-slide
had six independent ﬂow channels containing inde-
pendent HUVEC monolayers. For the duration of
shear experiments, the Ibidi chambers were housed in a
miniature incubator (Bioscience Tools, San Diego,
CA) and temperature was maintained at 37  C. Each
of the six individual channels was attached via Luer
connectors to a sterile silicone tube that was fed
through an Ismatec 32 channel roller pump (Ismatec,
Oak Harbor, WA). Medium at 37  C was ﬂowed over
cell monolayers at a rate of 8.5 mL/min, generating a
ﬂuid shear stress on the cell surface of 15 dyn/cm
2.
Fluorescence Microscopy
ImageswereacquiredusingacooledCCDcameraand
MaxIm acquisition software (Apogee Instruments)
housed on a Nikon Eclipse TE2000U inverted micro-
scopewith2090.50NAPlanFluorobjective.Eachimage
represents a 742 9 500 lm ﬁeld of approximately 300
conﬂuentcells.Nofewerthanthreeimageswereacquired
fromeachchannel.Acquiredimageswerestoredas16bit
Heparan Sulfate Regrowth Proﬁles 161linear ﬁles and processed with ImageJ software. The
background ﬂuorescence was deﬁned as the ﬂuorescence
observed with cells stained with secondary antibody and
DAPI only. Subtraction of the background yielded the
ﬁnal mean intensity values for cell surface heparan sul-
fate. The reported standard deviation represents the
spread of the mean intensity of multiple images, which
were acquired over multiple monolayers of the same
treatment group. For each experiment involving hepa-
rinase, a monolayer of HUVEC was stained for HS. At
leastthreeimageswereacquiredandthemeanintensityof
this group served as the value to which intensity values
from all other experimental groups were normalized.
Cell Shape Evaluation
Phase contrastimages obtainedat20 9 magniﬁcation
during heparan sulfate regrowth and immunostaining
step were evaluated using ImageJ. Fifteen cells randomly
chosen from each image were traced to obtain cell area
(a) and perimeter (p), which were used to calculate the
c i r c u l a r i t yi n d e x( S), based on the following formula:
S ¼
2
ﬃﬃﬃﬃﬃﬃ
pa
p
p
The alignment of the cells along the ﬂow axis was
calculated by measuring the angle Ø that is created by
the intersection of the line connecting the two farthest
points at the cell periphery with the ﬂow vector.
Statistical Analysis
All results are presented as mean ± standard devia-
tionandstatisticalsigniﬁcanceissettop<0.05.Statistics
for normally distributed data, such as from quantitative
ﬂuorescence microscopic images, was determined by
ANOVA and a Student–Newman–Keuls post hoc test if
more than 2 groups were being assessed. For circularity
index and alignment angle data that are not normally
distributed,theWilcoxontestforunpaireddatawasused
tocomparetwogroupsandKruskal–Wallistestwasused
to compare data from more than 2 groups. All statistical
analyses were performed using Kaleidagraph software
(Synergy Software, Reading, PA). Numbers of data
points in a set and other information pertinent to a par-
ticular data set are given in the ﬁgure captions.
RESULTS
Heparan Sulfate Levels are Constant Over Time
in Static Cells
Heparan sulfate levels did not change signiﬁcantly
for any time between 24 and 84 h after plating (Fig. 1).
The cells were seeded at 2.5 9 10
5 cells/cm
2, which is a
sufﬁciently high concentration to produce attachment
to the substrate within 24 h that does not require fur-
ther proliferation to achieve conﬂuence. The mean
ﬂuorescence intensity values range from 14.9 to 19.3
and no statistical differences were observed between
any time points (a = 0.05). The lack of a trend between
or signiﬁcant difference among any of the groups sig-
niﬁes that heparan sulfate content on HUVEC is stable
over time and that the acquisition method is valid.
Heparan Sulfate Levels Increase Under Shear
Application of 15 dyn/cm
2 laminar shear ﬂow to
HUVEC monolayers results in a 40% increase in HS
levels as compared to statically cultured HUVEC. The
time course for heparan sulfate growth is shown in
Fig. 2. HS levels begin to rise as cells are exposed to
shear for 12 h and continue to increase toward an
asymptote at long times (> 48 h).
To obtain a quantitative measure of the increasing
heparan sulfate levels, the data were ﬁtted to the fol-
lowing exponential function:
IðtÞ¼ymax  ð ymax   yminÞe
 t
s
This function includes terms for the HS concentra-
tion at the plateau (ymax), the starting HS concentra-
tion (ymin), and the observed time constant (s) for the
increase in heparan sulfate on the cell surface. The time
of half maximum, t1/2, is the time required for HS
abundance to reach a half-maximum on the EC surface
by the relationship t1/2 = s/ln(2). Values for s and the
time of half maximum (t1/2) for the curve ﬁt are tab-
ulated in Table 1. The observed time constant, s is
found to be 19 h between 0 and 96 h of shear exposure,
indicating that the heparan sulfate concentration on
cells has reached its half maximum after 13 h and
steady state (which is deﬁned here as within 5% of
ymax) after 19 h. The uncertainty in the experiments
does not preclude the possibility that the HS abun-
dance continues to increase modestly beyond 96 h.
Representative epiﬂuorescent microscopy images
used to quantify HS are presented in Fig. 3. The distri-
bution of HS is heterogeneous between individual cells
aswellasbetweenmulti-cellularareasofthemonolayer.
The distributions become more homogeneous with
exposure to laminar ﬂow (Fig. 3, top row). On cells that
havebeenexposedtoshearfor12 handmore,increased
heparan sulfate staining is clearly visible.
Endothelial Cells Align with the Flow Axis
In order to determine the kinetics for cell alignment,
phase contrast images were evaluated for changes in
GIANTSOS-ADAMS et al. 162circularity index and angle with respect to the ﬂow
vector. After 12 h of exposure to laminar ﬂow, we
documented that the cells have elongated from the
rounded shape characteristic of statically cultured
endothelial cells (mean circularity index S50 of 0.8) to a
signiﬁcantly lower circularity index of 0.5 (Fig. 4a).
There is a signiﬁcant difference in circularity between
statically cultured EC and the 12 h data set
(p<0.001), which is not different from time points
after 12 h. No statistical differences exist among data
sets between 12 and 96 h of laminar shear (p = 0.36).
After12 hofexposuretolaminarﬂow,ECalignment
with the ﬂow vector also had signiﬁcantly increased
(p<0.01)fromamedianangleof51 to32 withrespect
to the ﬂow vector (Fig. 4b). After 36 h, a further sig-
niﬁcantdecreaseinthealignmentangleismeasured(11 ,
p = 0.005). Between 36 and 96 h, no signiﬁcant differ-
ence in angle alignment is detected, indicating that
alignment in the direction of the ﬂow vector is complete
after 36 h. These data are in agreement with previously
reported studies of cellular elongation and align-
ment
34,44 and form the basis for comparison with cells
subjected to heparan sulfate degradation.
Heparan Sulfate is Restored 12 h After Heparinase
Injury Under Laminar Flow
The HUVEC monolayer was subjected to 24 h of
laminar ﬂow at 15 dyn/cm
2 then brieﬂy exposed to
heparinase III (Fig. 5, t = 0). Heparan sulfate was
allowed to regenerate at 37  C for discrete time periods
under shear and then the relative abundance was
measured using quantitative ﬂuorescence microscopy.
Data points in Fig. 5 have been normalized to the HS
signal from static untreated HUVEC, which were
grown in tandem with sheared endothelial cells to serve
as a control. The control for the heparanase treatment
is Fig. 2, the shear response without heparanase
exposure. The control with no shear and no heparan-
ase is a straight line at the unsheared static condition,
which is taken as 1.0 for all of the related ﬁgures.
The rise in HS levels begins almost immediately;
approximately 35% of the starting concentration of
HS has returned after 3 h, after which point a plateau
emerges where the rate of HS increase slows until after
12 h. After 24 h, the data have reached steady state
and no net increase in HS is observed for any time
point thereafter. Based on a single exponential model,
the observed time constant for the restoration of the
heparan sulfate fraction of the glycocalyx is 11.8 h as
shown in Fig. 5.
Heparan Sulfate is Restored Within 20 h Under
Static Condition
Experiments analogous to those reported above for
cells under shear stress were also conducted on static
cultured EC by exposing them to heparinase III. It is
found that static cultured EC regenerated heparan
sulfate at a slower rate than cells exposed to high shear
stress (Fig. 6). Following heparinase exposure, HS
exhibited a similar trend as seen in high shear pheno-
type EC: an initial burst phase of regrowth within the
ﬁrst 6 h, after which time HS levels reach steady state
within 20 h. The difference between static and ﬂow
conditions lies in the time required to reach a steady
state equal to the HS level for each phenotype not
exposed to heparinase. Fitting the data to a simple
exponential equation yields an observed time constant
of 20 h. Thus, the time necessary for HS restoration on
statically cultured cells is almost twice as long than the
time required for restoration on endothelium under
ﬂow. This difference may be attributable to differences
in the endocytosis and exocytosis rates for the two
phenotypes,
Heparinase-treated endothelial cells in static culture
were unable to regenerate apical heparan sulfate after
6 h when the endocytic/exocytotic pathways were
inhibited by cold temperature (Fig. 7). Following
heparinase injury, cells in static culture incubated for
6 h at 37  C were able to replenish 80% of the heparan
sulfate that is present on untreated control monolay-
ers. Low temperature completely abolishes the energy-
dependent exocytosis of nascent heparan sulfate. These
data also suggest that the HS turnover on EC follows
FIGURE 1. Heparan sulfate signal intensity from apical sur-
face of static cultured HUVEC monolayers is constant up to
84 h after seeding. Grey bars represent the mean heparan
sulfate ﬂuorescence intensity of 4–16 monolayer images of
different regions taken from 2 to 3 monolayers. No statistical
signiﬁcance between groups (p<0.05).
Heparan Sulfate Regrowth Proﬁles 163an energy-dependent mechanism such as endocytosis
and exocytosis.
Cell Alignment Under Shear Stress is Arrested
Following Heparinase Treatment
HUVEC, cultured for 24 h under laminar ﬂow, were
brieﬂy exposed to heparinase and were evaluated for
changes in cell shape. In Fig. 8, the probability densi-
ties are given for the angle of the cell with respect to the
ﬂow vector and the circularity index of the cells. No
signiﬁcant difference was observed for either criterion
after 3 h under shear following heparinase treatment
when compared to control monolayers under laminar
ﬂow for the same duration of time (Figs. 8a, 8e). After
12 h following heparinase treatment, there is a signif-
icant increase in circularity of the cells when compared
to control cells (Fig. 8b) that persists until 24 h fol-
lowing heparinase treatment (Fig. 8c), at which point
the circularity has recovered to control values
(Fig. 8d). After 12 h following heparinase treatment,
the angle of alignment to the ﬂow vector is signiﬁcantly
decreased compared to control (Fig. 8f). By 24 h, the
alignment has recovered and there is no difference
between heparinase treated EC and control monolay-
ers (Figs. 8g, 8h).
DISCUSSION
The current results demonstrate that under 15 dyn/
cm
2 of laminar ﬂow, the endothelial heparan sulfate
level increases by 1.4-fold after 19 h. The physiological
signiﬁcance of increased glycocalyx under ﬂow has been
demonstrated as regions of the carotid artery that are
exposed to atheroprotective ﬂow have a signiﬁcantly
thicker glycocalyx than regions under disturbed, or
atheroprone,ﬂow.
10,39Inculturedendothelialcells,high
shear stress increases production of the gene KLF2,
40
whose downstream effects include increased production
of proteoglycan 1, secretory granule (PRG1) and vari-
ous sulfotransferases (SULF1, SULF2)
29 that are pres-
entintheGolgitomodifynascentHS.Developmentofa
thicker glycocalyx may serve the atheroprotective phe-
notype by providing steric hindrances to inﬁltrating
cytokines and macrophages (reviewed in Lipowsky
23).
Heparan sulfate ﬂuorescence signals, collected at
various time points between inception and 72 h fol-
lowing the application of shear stress, were ﬁt to an
exponential function that describes the observed cell
FIGURE 2. Heparan sulfate growth proﬁle up to 96 h of shear. Data points are mean intensity of anti-heparan sulfate antibody
captured by epiﬂuorescence microscopy after discrete time periods of 15 dyn/cm
2 shear stress. The observed rate constant is
0.053 h
21. Error bars are 6 standard deviation of 4–16 monolayer images of different regions taken from 2 to 3 monolayers.
TABLE 1. Observed time constants (tau) and halﬂife data
(t1/2) for heparan sulfate growth on endothelial surface.
Treatment group s
a (h) t1/2
b (h)
15 dyn/cm
2 18.9 ± 10.2 13.1
15 dyn/cm
2 + HpaseIII 11.8 ± 3.2 8.2
0 dyn/cm
2 + HpaseIII 20.2 ± 0.4 13.9
aValues are ± ﬁt error.
bHalﬂife values are calculated from t1/2 = s/ln(2).
GIANTSOS-ADAMS et al. 164surface HS as a function of time and the starting and
plateau concentrations of cell surface HS (Fig. 2). The
time constant for the observed upregulation of HS
following shear onset is 18.8 h. If the data were
extended past 4 days, the HS levels may continue to
rise, as is observed when EC are exposed to shear stress
for 7 days and a 2-fold increase in HS is seen.
22
The rate of the decrease of the circularity index and
alignment angle follows the time course for HS
upregulation under laminar shear stress (Fig 4). Cir-
cularity is signiﬁcantly decreased, indicating signiﬁcant
cell elongation, after 12 h (Fig 4a) and the angle of
alignment to the ﬂow vector has also signiﬁcantly
decreased after 12 h and reaches its maximal alignment
FIGURE 3. HUVEC monolayer staining for anti-heparan sulfate after 12, 48, and 72 h of laminar ﬂow (15 dyn/cm
2). Top row, anti-
heparan sulfate antibody in green, cell nuclei in blue. Bottom row, corresponding phase contrast image.
FIGURE 4. Cumulative probability distributions for cells after time exposed to laminar ﬂow (15 dyn/cm
2) moving from static (0 h)
to 4-day shear (96 h) phenotype. (a) Circularity index decreases signiﬁcantly for cells after 12 h of shear (p<0.001, N = 45) but no
further reduction in the circularity index occurs at subsequent time points. (b) Angle of alignment to the ﬂow vector increases
signiﬁcantly after 12 h following heparinase treatment (p = 0.01, N = 45) and again after 36 h of shear (p = 0.005, N = 45).
Heparan Sulfate Regrowth Proﬁles 165after 36 h (Fig 4b). Interestingly, ﬂow conditioned EC
exposed to heparinase temporarily increase circularity
at 12 h after heparinase treatment (Fig. 8b) and the
angle of alignment also temporarily increases by 12 h
(Fig. 8f). These results indicate that the loss of the
ability of cells to sense shear causes them to become
more round and disorganized. In these experiments,
the cells are regenerating their HS glycocalyx at the
same time the loss of alignment is taking place. Thus,
there is a ﬁrst change towards the static conditioned
EC followed by a return to the atheroprotective phe-
notype following restoration of the glycocalyx
(Figs. 8c–8d and 8g–8h). EC without heparan sulfate
behave similarly to high shear phenotype EC that are
experiencing a sudden loss of shear stress. Remuzzi
et al.
34 have demonstrated that when ﬂow is removed
from high shear cultured EC, the mean elongation of
the cells persists for 3–4 h, after which point the
decrease in the cell’s aspect ratio is monotonic with
time.
34 In Figs. 8c and 8d, the circularity of the cells
has made a signiﬁcant recovery after 24 h and makes a
full recovery after 48 h, indicating that the restoration
of HS restores the ability of the cell to sense and
respond to an imposed ﬂow vector. The changes in EC
alignment are also returned to pre-treatment condi-
tions within 24 h (Figs. 8g, 8h), again reﬂecting the
time scale necessary for static cultured cells to respond
to changes in local ﬂow.
Our observations of a glycocalyx with a heparan
sulfate moiety that is removed by heparinase and
regrows in 1–2 days depending on the ﬂow conditions
is contradictory to the report by Potter and Damiano
that endothelial cells in culture do not posses any
glycocalyx.
31 In addition to the detection of a robust
heparin sulfate layer in vitro, we also ﬁnd that char-
acteristic functions of the endothelial cells to align with
the ﬂow direction and change to an elongated form
become lost when the glycocalyx HS is removed and
the mechanisms supporting these responses are
restored when the HS moiety is restored. The apparent
absence of a glycocalyx in earlier studies
31 may have
resulted from their method of enzyme delivery.
Enzymes were delivered and circulated in medium
lacking serum protein, which Adamson and Clough
1
have shown to collapse the glycocalyx. Also, their
in vitro model was a small long cylindrical cavity in a
collagen gel, and the ability of this model to reproduce
other known features of endothelial response reported
in previous papers has not been demonstrated. Recent
measurements by Ebong et al.
12 show signiﬁcant gly-
cocalyx on in vitro endothelial cell cultures. Additional
data are now available from confocal microscopy that
clearly identify the apical glycocalyx layer in vitro and
measure HS thickness in excess of 0.5 lm. Further-
more, the speciﬁcity of hyaluronidase for hyaluronic
acid has not been proven; therefore, its ability to
completely remove the glycocalyx, which is composed
of a variety of polysaccharides, is a surprising result.
Gao and Lipowsky
17 report that heparanase reduces
the volume of the glycocalyx by 60% and hyaluroni-
dase treatment results in a 20% reduction in total
glycocalyx volume. The remainder of some glycocalyx
FIGURE 5. Heparan sulfate regrowth proﬁles under laminar ﬂow (15 dyn/cm
2) following heparinase treatment at time 0. Each
point represents mean ﬂuorescence intensity of HS from 4 to 9 images. The observed time constant, tau, is 11.8 6 3.2 h.
GIANTSOS-ADAMS et al. 166would be expected if only certain components are
being targeted. We demonstrate that in vitro HUVEC
can produce a physiologically responsive glycocalyx, as
these cells align in the direction of ﬂow, and that a key
component of that glycocalyx is restored within a
physiologically relevant time frame following acute
enzymatic removal.
The overall shapes of the kinetic proﬁles of both
shear-conditioned and static cells recovering from
heparinase injury have similar biphasic properties.
Within 6–12 h, HS levels have recovered to 60–80% of
their ﬁnal concentration and the rapid increase in HS
suggests that the transit time between newly synthesized
HS and the Golgi apparatus is fast under both culture
conditions. There is evidence to support a quick turn-
over rate for heparan sulfate. Within 4 h following a
pulse-chase experiment, Carter et al.
8 show that only
35% of the initial [
3H]glucosamine label in the glyco-
calyx of HMEC-1 endothelial cells remains, suggesting
that heparan sulfate is quickly removed from the cell
surface and replaced with new material. In Figs. 5 and
6, there is an initial burst phase of heparan sulfate
regrowth, after which point the high shear proﬁle rises
and plateaus within 12 h; however, the corresponding
rate of regrowth under static conditions is much slower.
The biphasic nature of the regrowth proﬁles of both
phenotypes may indicate a change in the dominant HS
regrowth mechanism after 6 h. This suggests that it is
possible that there is a transition in the early injury
response from rapid vesicle release from the Golgi to a
dominant recycling of endosomes containing unmodi-
ﬁed syndecans back to the cell surface.
Our proposed model describes the active regenera-
tion and removal of heparan sulfate on the apical
FIGURE 6. Heparan sulfate regrowth proﬁles under static conditions following heparinase treatment at time 0. Each point rep-
resents mean ﬂuorescence intensity of HS from 4 to 9 images. The observed time constant, tau, is 20.2 6 0.4 h.
FIGURE 7. Heparan sulfate regeneration on cell surface is
exocytosis-dependent. For 6 h following heparinase expo-
sure, heparan sulfate exocytosis is diminished at 4  C (sha-
ded bar) and actively restores heparan sulfate at 37  C (grey
bar). Heparinase treatment groups are normalized to the static
control condition (black bar) receiving no heparinase.
* p<0.05 difference from control. N ‡ 4.
Heparan Sulfate Regrowth Proﬁles 167FIGURE 8. Cumulative probability distributions for heparinase-treated EC under laminar ﬂow (15 dyn/cm
2) measuring circularity
index (a–d) and angle of alignment (e–h). Circularity indices for cells under laminar ﬂow for (a) 3, (b) 12, (c) 24, and (d) 48 h
following heparinase treatment and time-matched controls. Signiﬁcant differences are shown after 12 and 24 h under laminar ﬂow
following enzymatic degradation. Angle of alignment data are given for cells under laminar ﬂow for (e) 3, (f) 12, (g) 24, and (h) 48 h
following heparinase treatment and time-matched controls. Signiﬁcant differences are shown at 12 h following heparinase treat-
ment. (N = 45 cells per group from 3 separate monolayers).
GIANTSOS-ADAMS et al. 168surface of endothelial cells and is presented in Fig. 9.
Heparan sulfate proteoglycans (HSPG) are produced
de novo from vesicles that bud from the trans-Golgi
compartment and appear on the cell surface within
12 min.
38 Heparan sulfate is then either shed from the
surface or internalized into the cell.
4 Reported rates for
internalization vary from 30 min
38 to 4 h,
43 but it is
generally agreed that the mode of entry is via a clath-
rin- and caveolae-independent mechanism that likely
involves macropinocytosis
27 and/or lipid rafts.
16,21
Following endocytosis, it has been reported that
HSPG are swiftly localized to the late endosome,
30
however, there are reports of a rapid recycling mech-
anism that may involve early endosomes.
4,38,45
Membrane recycling may balance the endocytic
removal of surface membrane to maintain cell size and
return unmodiﬁed proteins and lipids to the surface.
Bai et al.
4 have reported syndecan recycling and in
kinetic studies, recycling was shown to be a dynamic
process that occurs within minutes.
38 Takeuchi et al.
38
have measured syndecan turnover kinetics and calcu-
late that cell surface heparan sulfate recycles to and
from an intracellular compartment approximately 10
times before degradation under low calcium conditions.
Zimmermann et al.
45 have identiﬁed a role for syntenin,
which can bind PIP2 and syndecan, in the release of
syndecans from ADP-ribosylation factor 6 (Arf6)-
associated recycling endosomes. A mechanism for
heparan sulfate recycling is included in our model as it
may be a key component of endothelial homeostasis.
We assume that the concentration of HS in the
surface glycocalyx layer is governed by ﬁve pathways:
(1) uninhibited HS transport of HS-containing vesicles
from the Golgi to the membrane surface of the cell; (2)
shedding of HS and HS-binding transmembrane pro-
teins from the surface to the plasma; (3) endocytosis;
(4) exocytosis; and (5) lysosomal degradation within
the cell. Endocytosis and exocytosis are active trans-
port processes which depend, respectively, on the sur-
face concentration and the concentration of HS in
vesicles diﬀusing freely within the cytoplasm. In addi-
tion to the three dynamic processes (1), (3), and (4) that
are associated with the cell membrane, we include two
additional loss mechanisms: (2) shedding of the HS
from the surface from circulating cytokine cleavage
and (5) the loss of cytoplasmic vesicles through endo-
somal activity. The model closely resembles the trans-
port processes described by Gross and Lodish for the
degradation of erythropoietin.
19 The following equa-
tions describe the change in surface heparan sulfate
over time based on these four mechanisms:
d½HSsurface 
dt
¼ kgolgi HSgolgi
  
þ kexo HSee ½ 
  kendo HSsurface ½    kshed HSsurface ½  ð 1Þ
d½HSee 
dt
¼ kendo½HSsurface  kexo½HSee  kle½HSee ð 2Þ
d½HSle 
dt
¼ kle½HSee  klys½HSle ð 3Þ
d½HSlys 
dt
¼ klys½HSle  k ½HSlys ð 4Þ
All concentrations [HSxx] are referenced to a unit
surface area of the cell, i.e., the cytoplasm is consid-
ered well mixed to this operation. Subscript ‘‘ee’’ refers
to the cytoplasmic space (early endosomes), and ‘‘le’’
refers to the late endosomes of the terminal lysis
pathway. Equation (1) describes the change in cell
surface HS as a function of HS production from the
Golgi and also replenishment from early endosomes
via exocytosis, its removal via endocytosis and shed-
ding, and its replenishment by exocytosis of early
endosomes within the cytoplasm. Equations (2) and
(3) track intracellular HS in early and late endosomes,
respectively, and Eq. (4) describes the process of
transfer from late endosomes to lysosomes and the loss
of the degradation products from the lysosomes. The
rate constants that are used in the model are listed in
Table 2 and Table 3 contains the initial and ﬁnal
concentrations of each compartment described by Eqs.
(1)–(4). The model predictions of heparan sulfate
regrowth are shown alongside experimental data in
Figs. 10a and 10b for the static and shear conditions,
respectively.
Several assumptions were made in order to develop
a suﬃciently simple and useful model, as shown in
Figure 9. The ﬁrst assumption is that all labeled hep-
aran sulfate behaves identically. The model for the
intracellular behavior of HS was based upon on the
shape of the curve that describes [HSsurface], which was
obtained experimentally. The antibodies that targeted
cell surface HS did not differentiate between HS on
syndecans or glypicans so we do not differentiate
between different transmembrane proteoglycans. Sec-
ond, the rate of HS release from the Golgi is held
constant while the rates of membrane vesicles traf-
ﬁcking to the surface is varied, depending on whether
the cell has the high shear or static phenotype. Evi-
dence for this behavior comes from Arisaka et al.,
3
wherein high shear stress did not change the synthesis
rate of HS but did increase the total rate of transport
of synthesized GAG to the cell surface. Last, we
assume that HS production is complete as it exits the
Golgi, which has been established as the location of
HS biosynthesis and nascent enzymatic alteration
(reviewed by Esko and Lindahl
13). We acknowledge
that the glycocalyx is a dynamic layer subject to
constant real-time modiﬁcations in response to
Heparan Sulfate Regrowth Proﬁles 169environmental changes, however, these details are
beyond the scope of the model.
The static parameters outlined in Tables 2 and 3
satisfy the conditions set forth by Bai et al.
4 that
quantiﬁes heparan sulfate at the static endothelial
surface, inside the cell, and in the medium. Using
pulse-chase experiments with
35S radiolabel, Bai et al.
4
determine that the steady-state ratio for HS inside the
cell to the surface is 2:1 and similarly reveal that in the
untreated wild-type cell, the concentrations of HS on
the surface and in the lysosome are approximately
equal. While these numbers are not given explicitly in
the text, they may be extrapolated by integration of the
liquid chromatograms. The ratios derived from Bai
et al.
4 are mirrored in the concentration of HS in each
compartment of the model after steady state is reached
(Fig. 11). For the surface concentration, that time is
20.2 h however, for the lysosomal compartment the
time to reach steady state is extended because of the
time required to bring the upstream early and late
endosome compartments to full equilibrium.
An evaluation of the model for EC under high shear
is shown in Fig. 12. To increase the output of HS to
the surface, the de novo production of HS in the Golgi
was increased, while its rate of trafﬁcking to the sur-
face remains unchanged, in agreement with ﬁndings
TABLE 2. Model-derived rate constants.
Name Process
Rate constant (h
 1)
Static Shear
kGolgi de novo HS production from Golgi apparatus 0.96 0.96
kexo HS exocytosis from recycling vesicles 0.075 0.05
kendo HS endocytosis 0.025 0.05
kle HS trafﬁcking to late endosome 0.01 0.01
klys HS trafﬁcking to lysosome 0.01 0.01
kshed HS cell surface shedding 0.10 0.033
kdeg HS release from lysosome 0.005 0.005
FIGURE 9. Kinetic model of heparan sulfate turnover from cell surface. Heparan sulfate concentration on cell surface is modeled
as a function of the rate of HS production from the Golgi apparatus (kgolgi), endocytosis (kendo) from the cell surface, and
exocytosis from recycling vesicles (kexo) and from the late endosome (kendole).
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3 The plateau abundance of heparan
sulfate is reached more quickly in this model due to a
3-fold increase in shedding under shear conditions and
a concurrent increase in trafﬁcking of HS from the
Golgi to the surface. While it is clear in the literature
that shear stress induces shedding under ischemic
conditions (reviewed by Mulivor et al.
24), the shedding
rate has not been explored under high shear stress for
otherwise normal endothelium. An increase in the ratio
of exocytosis to endocytosis from 1:1 to 3:1 for this
model decreases the time necessary to reach steady
state on the EC surface. The HS concentration of the
intracellular compartment of high shear EC is
approximately equal to that of the static EC, which
complements the observation by Arisaka et al.
3
A close examination of the ability of the model to ﬁt
the data for both the static cell recovery and the
sheared cell recovery suggests that there may be an
additional unmodeled mechanism acting at short times
to release HS-containing vesicles to the surface to
recover HS much faster than the current model
can predict. This would imply that some store of
HS-containing vesicles, either in the cytoplasm or in the
Golgi themselves, are liberated in the event that the
external glycocalyx layer is compromised. It will be an
interesting challenge to attempt toidentify thisunknown
HS source that appears in the recovery process.
Shear induced elongation and alignment with the
ﬂow vector are attributed in part to the role of heparan
sulfate in mechanotransduction.
44 Here the rate of
alignment of the cells to the ﬂow axis is evaluated in
tandem with shear-mediated increases in luminal hep-
aran sulfate. Endothelial cells under shear stress begin
to align with the ﬂow vector within 12 h, but have not
completely aligned until 36 h have passed (Fig. 5b).
The circular cell shape that is characteristic of statically
cultured endothelial cells has signiﬁcantly elongated
after 12 h, which is on par with signiﬁcant increases in
TABLE 3. Initial and ﬁnal HS abundances as model parameters.
Name Compartment
Initial concentration
a,b Steady state concentration
a
t =0 t = 1000 h
Shear Static Shear Static
[HSGolgi] Golgi apparatus 0.155 0.05 0.155 0.05
[HSee] Early endosome 0.4 0.4 0.4 0.4
[HSle] Late endosome 0.4 0.4 0.4 0.4
[HSlys] Lysosome 0.85 1.23 0.85 1.23
[HSsurface] Cell surface 0.1 0.1 1.45 1.10
aRelative to initial HS surface concentration.
bFollowing heparinase treatment.
FIGURE 10. Model predictions closely follow experimental data. Model prediction (thin black line) is plotted with experimental
data (ﬁlled circles) from heparan sulfate concentration following heparinase treatment for (a) static and (b) shear-conditioned
HUVEC (15 dyn/cm
2). Exponential ﬁt to experimental data is represented by the thick blue line.
Heparan Sulfate Regrowth Proﬁles 171heparan sulfate as the cells move from static to ﬂow
condition. These results indicate that cell motility is a
slower event than elongation, but both phenomena
reach a plateau after 36 h. Brief removal of heparan
sulfate does not have an effect on cell shape or motil-
ity, but it is possible that prolonged exposure to
enzymatic degradation could cause the cells to revert to
a static phenotype with an extended loss of the ability
to sense and respond to mechanical stimuli.
CONCLUSIONS
In this work, we demonstrate quantitatively the
increases of heparan sulfate on the endothelial surface
in response to high shear stress and validate the results
using quantitative ﬂuorescence microscopy. We pres-
ent a time course for the regeneration of heparan sul-
fate on the endothelial cell surface following
heparinase injury and correlate that recovery course
FIGURE 11. Model prediction for HS trafﬁcking and cell surface regrowth in static phenotype EC following heparinase treatment.
FIGURE 12. Model prediction for HS trafﬁcking and cell surface regrowth in shear phenotype EC following heparinase treatment.
GIANTSOS-ADAMS et al. 172with cell elongation mechanics, thus demonstrating an
active and relevant glycocalyx present on cultured
endothelium. A model for the uptake and release of
apical heparan sulfate is presented that couples the
experimental HS recovery rate constants with pub-
lished membrane traﬃcking constants to provide a
phenotype-speciﬁc picture of HS traﬃcking on the
endothelial surface.
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